India gears up for Covid-19 Vaccine; 130 crore await DGCI's nod
COVID-19 vaccine- Serum Institute of India In a major hope to battle the global pandemic, India has now granted approval to Covishield, Serum Institute of India’s vaccine candidate, as per sources. Gearing up for to begin the process of immunisation, a high-level meeting was also convened today today. Post which, it was announced that a dry vaccine drive that will be starting tomorrow, January 2. UK has already given its nod to the AstraZeneca vaccine for emergency use. Covishield vaccine is likely to cost Rs 440 per person. IT Minister Ravi Shankar Prasad recently announced the launch of ...